These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 21473721)

  • 1. Making the cut: untangling clinical protein biomarker discovery and validation.
    Gold L; Williams S; Janjic N; Saccomano N; Steele F
    Biomark Med; 2011 Apr; 5(2):189-91. PubMed ID: 21473721
    [No Abstract]   [Full Text] [Related]  

  • 2. Aptamer microarray mediated capture and mass spectrometry identification of biomarker in serum samples.
    Ahn JY; Lee SW; Kang HS; Jo M; Lee DK; Laurell T; Kim S
    J Proteome Res; 2010 Nov; 9(11):5568-73. PubMed ID: 20806970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peptide aptamers for small molecule drug discovery.
    Bardou C; Borie C; Bickle M; Rudkin BB; Colas P
    Methods Mol Biol; 2009; 535():373-88. PubMed ID: 19377984
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aptamers: a promising tool for cancer imaging, diagnosis, and therapy.
    Liu K; Lin B; Lan X
    J Cell Biochem; 2013 Feb; 114(2):250-5. PubMed ID: 22949372
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validation of immunoassay for protein biomarkers: bioanalytical study plan implementation to support pre-clinical and clinical studies.
    Valentin MA; Ma S; Zhao A; Legay F; Avrameas A
    J Pharm Biomed Anal; 2011 Jul; 55(5):869-77. PubMed ID: 21530130
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peptide aptamers as guides for small-molecule drug discovery.
    Baines IC; Colas P
    Drug Discov Today; 2006 Apr; 11(7-8):334-41. PubMed ID: 16580975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional aptamers and aptazymes in biotechnology, diagnostics, and therapy.
    Famulok M; Hartig JS; Mayer G
    Chem Rev; 2007 Sep; 107(9):3715-43. PubMed ID: 17715981
    [No Abstract]   [Full Text] [Related]  

  • 8. Body fluid proteomics for biomarker discovery: lessons from the past hold the key to success in the future.
    Good DM; Thongboonkerd V; Novak J; Bascands JL; Schanstra JP; Coon JJ; Dominiczak A; Mischak H
    J Proteome Res; 2007 Dec; 6(12):4549-55. PubMed ID: 17970587
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selection and characterization of large collections of peptide aptamers through optimized yeast two-hybrid procedures.
    Bickle MB; Dusserre E; Moncorgé O; Bottin H; Colas P
    Nat Protoc; 2006; 1(3):1066-91. PubMed ID: 17406388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protein biomarker discovery and validation: the long and uncertain path to clinical utility.
    Rifai N; Gillette MA; Carr SA
    Nat Biotechnol; 2006 Aug; 24(8):971-83. PubMed ID: 16900146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Translation of neurological biomarkers to clinically relevant platforms.
    Hayes RL; Robinson G; Muller U; Wang KK
    Methods Mol Biol; 2009; 566():303-13. PubMed ID: 20058180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alignment of LC-MS images, with applications to biomarker discovery and protein identification.
    Vandenbogaert M; Li-Thiao-Té S; Kaltenbach HM; Zhang R; Aittokallio T; Schwikowski B
    Proteomics; 2008 Feb; 8(4):650-72. PubMed ID: 18297649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Developing an integrated proteo-genomic approach for the characterisation of biomarkers for the identification of Bacillus anthracis.
    Misra RV; Ahmod NZ; Parker R; Fang M; Shah H; Gharbia S
    J Microbiol Methods; 2012 Feb; 88(2):237-47. PubMed ID: 22178189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biomarker discovery: validation and decision-making in product development.
    Niedbala RS; Mauck C; Harrison P; Doncel GF
    Sex Transm Dis; 2009 Mar; 36(3 Suppl):S76-80. PubMed ID: 19218888
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiplex immunoassays: an invaluable tool for biomarker discovery and validation.
    Lehr S
    Arch Physiol Biochem; 2012 Oct; 118(4):191. PubMed ID: 22747464
    [No Abstract]   [Full Text] [Related]  

  • 16. Potential biomarkers for the diagnosis of stroke.
    Jensen MB; Chacon MR; Sattin JA; Levine RL; Vemuganti R
    Expert Rev Cardiovasc Ther; 2009 Apr; 7(4):389-93. PubMed ID: 19379063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biomarker validation in blood specimens by selected reaction monitoring mass spectrometry of N-glycosites.
    Ossola R; Schiess R; Picotti P; Rinner O; Reiter L; Aebersold R
    Methods Mol Biol; 2011; 728():179-94. PubMed ID: 21468948
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How shall we use the proteomics toolbox for biomarker discovery?
    Lescuyer P; Hochstrasser D; Rabilloud T
    J Proteome Res; 2007 Sep; 6(9):3371-6. PubMed ID: 17655344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biomarkers of sepsis.
    Marshall JC; Reinhart K;
    Crit Care Med; 2009 Jul; 37(7):2290-8. PubMed ID: 19487943
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Traumatic brain injury biomarkers: from pipeline to diagnostic assay development.
    Oli MW; Hayes RL; Robinson G; Wang KK
    Methods Mol Biol; 2009; 566():293-302. PubMed ID: 20058179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.